+48.2%
GSK vs USHY
+20.9%
+27.3%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | USHY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.0% | -0.5% | -0.6% | -0.7% |
| 7D | -5.4% | -0.7% | -4.7% | -4.9% |
| 30D | -4.6% | -0.5% | -4.1% | -4.2% |
| 3M | -5.1% | +0.5% | -5.6% | -5.5% |
| 6M | -11.4% | +1.5% | -12.9% | -12.4% |
| YTD | +0.7% | +1.7% | -1.0% | -0.5% |
| 1Y | +23.0% | +3.5% | +19.5% | +20.0% |
| 3Y | +48.0% | +27.2% | +20.8% | +25.9% |
| 5Y | +48.2% | +21.0% | +27.2% | +29.8% |
| All | +48.2% | +20.9% | +27.3% | +29.8% |
Cumulative growth
Daily Returns
Daily percentage return beside USHY.
Daily Out/Under-Performance
Portfolio return minus USHY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × USHY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded USHY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling